SCHEMBL26548720

SCHEMBL26548720

C[Si](C)(C)c1ccc(-c2ccc3ccc(-c4ccc(-c5ccncc5)nc4)cc3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAK O14976 1/20 0.40
PDGFRB P09619 7/20 0.40
PDGFRA P16234 7/20 0.40
DYRK1A Q13627 3/20 0.39
MAP4K4 O95819 2/20 0.39
CLK2 P49760 2/20 0.39
ROCK1 Q13464 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
JAK2 O60674 1/20 0.39
ROCK2 O75116 1/20 0.39
RPS6KB1 P23443 1/20 0.39
TYK2 P29597 1/20 0.39
GSK3B P49841 1/20 0.39
CDK8 P49336 1/20 0.39
CDK7 P50613 1/20 0.39
CDK9 P50750 1/20 0.39
CDK5 Q00535 1/20 0.39
ACVR1 Q04771 1/20 0.39
LRRK2 Q5S007 1/20 0.39
DYRK1B Q9Y463 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548205 0.96 PDGFRB (0.43) GAKPDGFRBPDGFRADYRK1AMAP4K4
SCHEMBL26548853 0.93 HSD17B1 (0.40) PRKCZCYP19A1PIK3CDPIK3CAPIK3CB
SCHEMBL26549230 0.89 GAK (0.54) GAKPDGFRBPDGFRADYRK1AMAP4K4
SCHEMBL26548367 0.88 HSD17B1 (0.41) PDGFRBPDGFRACYP19A1CYP17A1CYP11B2
SCHEMBL26548908 0.86 DYRK1A (0.49) GAKDYRK1AMAP4K4CLK2ROCK1
SCHEMBL26548593 0.86 DYRK1A (0.49) GAKDYRK1AMAP4K4CLK2ROCK1
SCHEMBL26548850 0.86 TDO2 (0.45) CYP11B2CYP11B1
SCHEMBL26548845 0.86 TDO2 (0.45) CYP11B2CYP11B1
SCHEMBL26548838 0.86 TDO2 (0.42) PDGFRBPDGFRAROCK1CDK8PIK3CD
SCHEMBL26548851 0.86 TDO2 (0.42) PDGFRBPDGFRAROCK1CDK8PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 GAK 3896/4885PDGFRB 4867/4885PDGFRA 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.